Sunil Abhyankar

Health Innovations (United States) — United States

Medicine · Health Sciences

30h-index4.5kcitations339works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(129), Acute Myeloid Leukemia Research(72), Chronic Myeloid Leukemia Treatments(43), CAR-T cell therapy research(42), Acute Lymphoblastic Leukemia research(34)

Publications339 total

Reduction of Stem Cell Collection Pheresis Time in Patients with Large Numbers of Circulating CD34+ with Upfront Plerixafor Use
Transplantation and Cellular Therapy·2026
Outcomes after Bone Marrow Versus Peripheral Blood Matched Unrelated Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based GVHD Prophylaxis
Transplantation and Cellular Therapy·2026
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Single-Center Experience
Transplantation and Cellular Therapy·2026
A Phase 2, Open Label Study to Evaluate Vimseltinib in Adults with Active Chronic Graft-Versus-Host Disease after Failure of Prior Systemic Therapies
Transplantation and Cellular Therapy·2026
Impact of Donor Age on Transplant Outcomes in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide
Transplantation and Cellular Therapy·2026
Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation
Frontiers in Hematology·2026Open Access
Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis
Hematology Transfusion and Cell Therapy·2025Open Access
A phase 1b study on the safety of Wharton’s jelly mesenchymal stromal cells in the treatment of acute graft-versus-host disease
Cytotherapy·2025Open Access
Utility of neurotoxicity investigations in CD19 and BCMA CART recipients with ICANS
Blood Immunology & Cellular Therapy·2025Open Access
Vancomycin-resistant enterococci (VRE) colonization is associated with worse outcomes post allogenic hemopoietic stem cell transplantation
Blood·2025
Impact of donor age on transplant outcomes in unrelated allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide-based gvhd prophylaxis
Blood·2025Open Access
Concurrent intravenous immunoglobulin and platelet transfusion for refractory alloimmune thrombocytopenia in patients undergoing allogeneic hematopoietic stem cell transplantation
Hematology Transfusion and Cell Therapy·2025Open Access
Advances in stem cell and cellular therapeutics from the 9th Midwest Conference on Cell Therapy and Regenerative Medicine
Molecular Therapy·2025
Large-scale manufacturing of immunosuppressive extracellular vesicles for human clinical trials
Cytotherapy·2025· 5 citedOpen Access
89 | TANDEM CD20‐19‐DIRECTED NON‐CRYOPRESERVED CAR‐T CELLS–ZAMTOCABTAGENE AUTOLEUCEL (ZAMTO‐CEL)—IN PATIENTS WITH RELAPSED/REFRACTORY CNS LYMPHOMA IN DALY II US STUDY
Hematological Oncology·2025Open Access
105 | INTERIM RESULTS OF TANDEM CD20‐CD19‐DIRECTED NON‐CRYOPRESERVED CAR‐T CELLS—ZAMTOCABTAGENE AUTOLEUCEL IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
Hematological Oncology·2025· 1 citedOpen Access
Reduced dose fludarabine and cyclophosphamide lymphodepletion before tumor-infiltrating lymphocyte therapy in melanoma
Future Oncology·2025· 1 cited
Abstract CT066: Therapeutic advances for high-risk and steroid-refractory aGvHD: Promising results from the phase 1b study of MSCTC-0010 Wharton's jelly mesenchymal stem cells (WJMSC)
Cancer Research·2025
A Phase Ib Study to Expand on the Safety of Wharton's Jelly Mesenchymal Stem Cells for Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease
Transplantation and Cellular Therapy·2025
Impact of Graft Cell Dose on Outcomes after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis
Transplantation and Cellular Therapy·2025Open Access
page 1 of 17Next →

Frequent Co-authors

Joseph P. McGuirk(28), Siddhartha Ganguly(16), Omar S. Aljitawi(12), Anurag K. Singh(9), Tara L. Lin(6), Leyla Shune(6), Clint Divine(6), Ramesh Balusu(5), Kyle R. Brownback(5), Mary M. Horowitz(4), Kamar Godder(4), Warren Fiskus(4), Casey Williams(4), Kapil N. Bhalla(4), Muhammad Umair Mushtaq(4), Moazzam Shahzad(4), Sibgha Gull Chaudhary(4), Nausheen Ahmed(4), Aleksandr Lazaryan(3), Daniel J. Weisdorf(3)